Slide background
Slide background




Medicinal VIPR Package

ID 8337 | | Visite: 1563 | Documenti Chemicals EntiPermalink: https://www.certifico.com/id/8337

218 19

Medicinal VIPR Package - Lifetime Performance of Drug Delivery Device

EIGA Doc. 218/19

One of the major developments on how medicinal gases are delivered to patients has been the introduction of cylinders fitted with valves that have an integrated pressure regulator.

These medical gas cylinder packages fitted with a valve with integrated pressure regulators (VIPRs) offer a number of significant benefits to both the healthcare professional and the homecare patient when administering the medicinal gas for clinical treatment.

The medical VIPR packages have now been in service for more than twenty years and they have proven to be both reliable and beneficial to those administering medicinal gas from cylinders. Although the medical VIPR packages are used predominantly in medical oxygen service, they can be used for other gases and gas mixtures, including medical air and nitrous oxide/oxygen analgesic gas mixtures.

Although the intended performance of the medical gas VIPR (when initially put into service) is specified in the valve manufacturer’s technical file, the pharmaceutical legislation also requires the gas manufacturer to ensure that the valve is performing correctly each time the cylinder is filled and supplied for patient use over its complete service life. It is important that the VIPR will control the gas supply accurately, as both over and under administration of the gas can lead to patient harm. By establishing a process of valve performance verification and by trending any report received from the customer, it is possible to provide the appropriate assurances that the medical VIPR will function correctly.

This publication is a guideline that describes the basic requirements for the tests that the VIPR manufacturer should perform and the performance checks carried out by the gas manufacturer. This will assist to ensure that the VIPR performs as intended throughout its service life.

This publication applies to filled medicinal VIPR packages used to administer medicinal gases by healthcare professionals and homecare patients.
_________

Table of Contents
Introduction
Scope and purpose
2.1 Scope
2.2 Purpose
Definitions
3.1 Publication terminology
3.2 Technical definitions
Intended performance of medicinal VIPRs
Test requirement for VIPR manufacturers
5.1 General
5.2 Cleaning
5.3 Test conditions for additional tests
5.4 Additional tests to be performed on every medicinal VIPR
Requirements for gas manufacturers
6.1 Initial qualification of a model of VIPR
6.2 Incoming inspection
6.3 VIPR fitting
6.4 First fill
6.5 Post-maintenance fill
Medical VIPR package refilling 
7.1 Pre-fill testing 
7.2 Tests and inspection after filling 
Management of rejected VIPRs at gas manufacturer
Reporting to health authorities 
References 
Other references 
Appendix 1 – Typical Risk Assessment
Appendix 2 - Technical part on medicinal VIPR
Appendix 3 - Flow delivery to the patient
Appendix 4 – Regulatory background

Fonte: EIGA

Collegati:

Descrizione Livello Dimensione Downloads
Allegato riservato Medicinal VIPR Package.pdf
EIGA Doc. 218/19
357 kB 0

Tags: Chemicals Abbonati Chemicals

Articoli correlati

Ultimi archiviati Chemicals

Recast Drinking Water Directive
Lug 01, 2022 52

Recast Drinking Water Directive, state of play

Recast Drinking Water Directive, state of play EU JRC - June 2022 Guidance note for the analysis of microbiological parameters The quality of drinking water in the European Union is verified by measuring parameters established in the recast of the Drinking Water Directive (DWD) 2020/2184. Compared… Leggi tutto
Giu 24, 2022 59

Regolamento (UE) 2021/2142

Regolamento (UE) 2021/2142 Regolamento (UE) 2021/2142 della Commissione del 3 dicembre 2021 che modifica il regolamento (CE) n. 1881/2006 per quanto riguarda i tenori massimi di alcaloidi oppiacei in alcuni prodotti alimentari. (GU L 433 del 6.12.2021) Collegati[box-note]Regolamento (CE) n.… Leggi tutto
Faster action on groups of harmful chemicals
Giu 17, 2022 87

ECHA - Integrated Regulatory Strategy (IRS) Annual Report 2021

ECHA - Integrated Regulatory Strategy (IRS) Annual Report 2021 Faster action on groups of harmful chemicals - Integrated Regulatory Strategy Annual Report June 2022 Helsinki, 17 giugno 2022 È stato pubblicato il quarto rapporto dell'ECHA nell'ambito della sua strategia di regolamentazione… Leggi tutto
Mag 31, 2022 115

Decreto 11 ottobre 2001

Decreto 11 ottobre 2001 Condizioni per l'utilizzo dei trasformatori contenenti PCB in attesa della decontaminazione o dello smaltimento. (GU n.255 del 02.11.2001) Collegati
D.P.R. 24 maggio 1988, n. 216Decreto Legislativo 22 maggio 1999 n. 209
Leggi tutto
Mag 31, 2022 130

D.P.R. 24 maggio 1988, n. 216

D.P.R. 24 maggio 1988, n. 216 Attuazione della direttiva CEE n. 85/467 recante sesta modifica (PCB/PCT) della direttiva CEE n. 76/769 concernente il ravvicinamento delle disposizioni legislative, regolamentari ed amministrative degli Stati membri relative alle restrizioni in materia di immissione… Leggi tutto

Più letti Chemicals

Regolamento  CE  n  178 2002
Mar 17, 2022 65064

Regolamento (CE) N. 178/2002

Regolamento (CE) n. 178/2002 Regolamento (CE) n. 178/2002 del Parlamento europeo e del Consiglio del 28 gennaio 2002 che stabilisce i principi e i requisiti generali della legislazione alimentare, istituisce l'Autorità europea per la sicurezza alimentare e fissa procedure nel campo della sicurezza… Leggi tutto